Evaluation of Novel and Emerging Practices Related to COVID-19 Health Disparities

The Scope of Work involves evaluating OT21-2103 grant recipients’ implementation of novel and emerging practices across the four NNPHI COVID-19 strategy areas. As a contractor, we will utilize the effectiveness and implementation dimensions of the RE-AIM framework to understand the processes and outcomes associated with these practices and other identified participatory methods. While funding for this project is 14 months, evaluation studies of each practice will remain short-term and timebound, ideally lasting between 4 and 6 months. In addition to these activities, the following tasks will be within our scope of work: Meet with NNPHI staff and key stakeholders to coordinate activities outlined in our work plan. · Understand the perspectives of internal and external stakeholders about this work, including, but not limited to, OT21-2103 grant recipients, local equity-focused partners, community members, NNPHI and other project subcontractors, and CDC staff. · Work directly with select grant recipients and their partners to develop and conduct evaluation studies of emerging and novel practices, using the selected RE-AIM framework dimensions. In partnership with NNPHI and CDC staff and selected grant recipients, we will: o Develop evaluation questions and methodology o Develop evaluation instruments for data collection o Conduct all evaluation activities (data collection and management, analysis, etc.) · Present findings via the suggested reporting systems (e.g., written evaluation report, electronic and virtual meetings), develop tools to translate into practice and include in the repository, and as funding allows, support the development of peer-reviewed documents and journal supplements. We will collaborate with NNPHI, CDC’s Center for State, Tribal, Local, and Territorial Support, and other national partners. The contract end date is July 31, 2023, with a potential for extension based on project needs and funding availability.